Pablo Lapuerta
Gründer bei 4m Therapeutics, Inc.
Profil
Pablo Lapuerta is the founder of 4M Therapeutics, Inc. He previously worked as an Executive Director-Global Medical Affairs at Bristol Myers Squibb Co. from 2009 to 2010.
From 2011 to 2020, he served as the Chief Medical Officer & Executive Vice President at Lexicon Pharmaceuticals, Inc. Prior to that, he was the Chief Medical Officer & SVP-Clinical Strategy at Cogentus Pharmaceuticals, Inc. from 2007 to 2009.
Additionally, he held positions as a Principal at the University of Southern California and Robert Wood Johnson Medical School.
Dr. Lapuerta obtained his doctorate degree from Harvard Medical School and his undergraduate degree from Harvard College.
Aktive Positionen von Pablo Lapuerta
| Unternehmen | Position | Beginn |
|---|---|---|
| 4m Therapeutics, Inc. | Gründer | - |
Ehemalige bekannte Positionen von Pablo Lapuerta
| Unternehmen | Position | Ende |
|---|---|---|
| LEXICON PHARMACEUTICALS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 30.09.2020 |
| BRISTOL-MYERS SQUIBB COMPANY | Technik-/Wissenschafts-/F&E-Leiter | - |
Cogentus Pharmaceuticals, Inc.
 Cogentus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Cogentus Pharmaceuticals, Inc. develops pharmaceutical products. Its investors include The Keffi Group, Prospect Venture Partners, Ridgeback Capital, Apothecary Capital, and Pinnacle Ventures. The company was founded by Mark A. Goldsmith in 2006 and is headquartered in Menlo Park, CA | Technik-/Wissenschafts-/F&E-Leiter | - |
University of Southern California
 University of Southern California Other Consumer ServicesConsumer Services University of Southern California is a private research university that mainly offers undergraduate, graduate & other higher education. The university was founded in 1880 and is headquartered in Los Angeles, CA. | Corporate Officer/Principal | - |
| Robert Wood Johnson Medical School | Corporate Officer/Principal | - |
Ausbildung von Pablo Lapuerta
| Harvard Medical School | Doctorate Degree |
| Harvard College | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| LEXICON PHARMACEUTICALS, INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Cogentus Pharmaceuticals, Inc.
Cogentus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Cogentus Pharmaceuticals, Inc. develops pharmaceutical products. Its investors include The Keffi Group, Prospect Venture Partners, Ridgeback Capital, Apothecary Capital, and Pinnacle Ventures. The company was founded by Mark A. Goldsmith in 2006 and is headquartered in Menlo Park, CA | Health Technology |
| 4m Therapeutics, Inc. |
